Genmab, a Danish company focused on developing antibody therapies for patients with cancer, opened a new site in Plainsboro, NJ. The company was awarded $8.4 million in tax credits over seven years by the Murphy Administration to develop the new location. Expanding presence in NJ “Our extension at the Princeton Forrestal Center will strengthen our… The post As some biotechs cut, Genmab unveils striking new site near Princeton appeared first on Drug Discovery and Development.
